Trending News

Daily Aspirin Use Can Increase Likelihood of Anemia in Older Adults

Daily Aspirin Use Can Increase Likelihood of Anemia in Older Adults

What did the research discover? Researchers wanted to find out if taking a small dose of aspirin every day could lead to anemia (a condition where you don’t have enough healthy red blood cells) and lower iron levels in the blood. To do this, they analyzed data from a large study called ASPREE. This study included 19,114 older adults living in the United States and...

Your Sleep Pattern Could Affect Your Risk of Diabetes

Your Sleep Pattern Could Affect Your Risk of Diabetes

What did the research discover? This study looked at how a person’s chronotype—whether they are a "morning person" or "night owl"—affects their risk of developing type 2 diabetes and whether lifestyle choices play a role. Researchers followed 63,676 middle-aged nurses who had no history of diabetes, cancer, or heart disease from 2009 to 2017. They divided...

FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023

FDA Greenlights Agamree for Duchenne Muscular Dystrophy on October 26, 2023

What is Agamree prescribed for?   Agamree is prescribed for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. What is Agamree and what does it do? Agamree,  pronounced ah gam' ree, (generic name: vamorolone), is a medication that was approved by the FDA to help treat Duchenne muscular dystrophy (DMD).  DMD...

FDA Approves Bimzelx for Plaque Psoriasis: A New Hope for Patients as of October 17, 2023

FDA Approves Bimzelx for Plaque Psoriasis: A New Hope for Patients as of October 17, 2023

What is Bimzelx prescribed for?  Bimzelx is prescribed to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. What is Bimzelx and what does it do? Bimzelx, pronounced bim zel’ ex, (generic name: bimekizumab-bkzx) is a medication approved by the FDA to help adults with moderate to severe plaque...